G Medical Innovations Holdings Profit Margin

G Medical Innovations Holdings posts a profit margin of -116.04% as of June 2022. That compares with -554.41% in the prior-year period — up 79.1% year over year. That is below the Healthcare sector average of 10.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, G Medical Innovations Holdings's profit margin was -554.41%. The latest reading is -116.04% — a 79.1% year-over-year increase (period ending June 2022). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 10.58% is typical. G Medical Innovations Holdings's -116.04% is lower that level. That is roughly 1196.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

G Medical Innovations Holdings's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -116.04% as of June 2022; use YoY and peer views to separate noise from signal.

Context for GMVDF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.58%), and (3) consistency with growth and profitability. This page covers the first two; G Medical Innovations Holdings's other metric pages and overview cover the third.